Medical and surgical management of advanced Parkinson's disease

dc.contributor.authorGodeiro Junior, Clécio de Oliveira
dc.contributor.authorAntonini, Angelo
dc.contributor.authorMoro, Elena
dc.contributor.authorReichmann, Heinz
dc.contributor.authorID0000-0002-4312-1633pt_BR
dc.date.accessioned2023-06-30T17:37:42Z
dc.date.available2023-06-30T17:37:42Z
dc.date.issued2018-03-23
dc.description.resumoAdvanced Parkinson's disease is characterized by the presence of motor fluctuations, various degree of dyskinesia, and disability with functional impact on activities of daily living and independence. Therapeutic management aims to extend levodopa benefit while minimizing motor complications and includes, in selected cases, the implementation of drug infusion and surgical techniques. In milder forms of motor complications, these can often be controlled with manipulation of levodopa dose and the introduction of supplemental therapies such as catechol-O-methyl transferase inhibitors, monoamine oxidase B inhibitors, and dopamine agonists including apomorphine. Clinical experience and evidence from published studies indicate that when these agents cannot satisfactorily control motor complications, patients should be assessed and considered for device-aided therapies. This review article summarizes some of the newer available therapeutic opportunities such as use of enzyme inhibitors like opicapone and safinamide, adenosine A2A receptor antagonists, apomorphine and levodopa/carbidopa intestinal gel infusion, deep brain stimulation including the role of closed-loop and adaptive stimulation, and MRI-guided focused ultrasound. © 2018 International Parkinson and Movement Disorder Societypt_BR
dc.identifier.citationGODEIRO JUNIOR, Clécio de Oliveira; MORO, Elena; ANTONINI, Angelo; REICHMANN, Heinz. Medical and surgical management of advanced Parkinson's disease. Movement Disorders, [S.L.], v. 33, n. 6, p. 900-908, 23 mar. 2018. Wiley. http://dx.doi.org/10.1002/mds.27340. Disponível em: https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.27340. Acesso em: 30 jun. 2023.pt_BR
dc.identifier.doihttps://doi.org/10.1002/mds.27340
dc.identifier.urihttps://repositorio.ufrn.br/handle/123456789/52940
dc.languageenpt_BR
dc.publisherMovement Disorderspt_BR
dc.subjectParkinson's diseasept_BR
dc.subjecttherapeutic managementpt_BR
dc.subjectlevodopa benefitpt_BR
dc.titleMedical and surgical management of advanced Parkinson's diseasept_BR
dc.typearticlept_BR

Arquivos

Licença do Pacote

Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.45 KB
Formato:
Item-specific license agreed upon to submission
Nenhuma Miniatura disponível
Baixar